Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreu Fabregat

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioanalysis|November 5, 2013
Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysisOscar J Pozo, Nik De Brabanter, Andreu Fabregat, et al.
Drug Testing and Analysis|November 4, 2014
Synthesis and characterization of 6β-hydroxyandrosterone and 6β-hydroxyetiocholanolone conjugated with glucuronic acidAristotelis Kotronoulas, Andreu Fabregat, Ignacio Alfonso, et al.
Orphanet Journal of Rare Diseases|April 17, 2014
Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control studyOscar J Pozo, Josep Marcos, Andreu Fabregat, et al.
Drug Testing and Analysis|November 23, 2017
Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part II: Intramuscular administrationAristotelis Kotronoulas, Àlex Gomez-Gómez, Andreu Fabregat, et al.
Drug Testing and Analysis|November 18, 2017
Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administrationAristotelis Kotronoulas, Àlex Gomez-Gómez, Andreu Fabregat, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 28, 2015
Urinary cysteinyl progestogens: Occurrence and originJosep Marcos, Marta Pol, Andreu Fabregat, et al.
Analytical Chemistry|July 23, 2015
Untargeted metabolomics in doping control: detection of new markers of testosterone misuse by ultrahigh performance liquid chromatography coupled to high-resolution mass spectrometryMontse Raro, María Ibáñez, Rubén Gil, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioanalysis|November 5, 2013
Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysisOscar J Pozo, Nik De Brabanter, Andreu Fabregat, et al.
Drug Testing and Analysis|November 4, 2014
Synthesis and characterization of 6β-hydroxyandrosterone and 6β-hydroxyetiocholanolone conjugated with glucuronic acidAristotelis Kotronoulas, Andreu Fabregat, Ignacio Alfonso, et al.
Orphanet Journal of Rare Diseases|April 17, 2014
Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control studyOscar J Pozo, Josep Marcos, Andreu Fabregat, et al.
Drug Testing and Analysis|November 23, 2017
Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part II: Intramuscular administrationAristotelis Kotronoulas, Àlex Gomez-Gómez, Andreu Fabregat, et al.
Drug Testing and Analysis|November 18, 2017
Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administrationAristotelis Kotronoulas, Àlex Gomez-Gómez, Andreu Fabregat, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 28, 2015
Urinary cysteinyl progestogens: Occurrence and originJosep Marcos, Marta Pol, Andreu Fabregat, et al.
Analytical Chemistry|July 23, 2015
Untargeted metabolomics in doping control: detection of new markers of testosterone misuse by ultrahigh performance liquid chromatography coupled to high-resolution mass spectrometryMontse Raro, María Ibáñez, Rubén Gil, et al.
Pageof 2